Literature DB >> 914981

The effects of oral melatonin on skin color and on the release of pituitary hormones.

J J Nordlund, A B Lerner.   

Abstract

We studied the effects of prolonged ingestion of melatonin, 1 g per day, on skin color and the serum levels of pituitary hormones in 5 human subjects with hyperpigmented skin. Melatonin lightened hyperpigmented skin of one patient with untreated adrenogenital syndrome, but had no effect on three patients' skin with idiopathic hyperpigmentation and one patient with treated Addison's disease. Melatonin appeared to depress the level of luteinizing hormone (LH) in serum and may have inhibited in some patients the release of growth hormone from the pituitary gland after stimulation by stress or L-dopa. The subjects all noted increased drowsiness but through studies on the eyes, liver, kidneys, and bone marrow revealed no other evidence of toxicity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914981     DOI: 10.1210/jcem-45-4-768

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

2.  Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men: lack of antagonism by flumazenil.

Authors:  R Luboshitzky; Z Shen-Orr; T Shochat; P Herer; P Lavie
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

3.  The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.

Authors:  D Esposti; P Lissoni; R Mauri; F Rovelli; L Orsenigo; S Pescia; G Vegetti; G Esposti; F Fraschini
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

4.  Melatonin regulates somatotrope and lactotrope function through common and distinct signaling pathways in cultured primary pituitary cells from female primates.

Authors:  Alejandro Ibáñez-Costa; José Córdoba-Chacón; Manuel D Gahete; Rhonda D Kineman; Justo P Castaño; Raúl M Luque
Journal:  Endocrinology       Date:  2014-12-29       Impact factor: 4.736

5.  Melatonin exerts oncostatic capacity and decreases melanogenesis in human MNT-1 melanoma cells.

Authors:  Konrad Kleszczyński; Tae-Kang Kim; Bernadetta Bilska; Michal Sarna; Krystian Mokrzynski; Agatha Stegemann; Elżbieta Pyza; Russel J Reiter; Kerstin Steinbrink; Markus Böhm; Andrzej T Slominski
Journal:  J Pineal Res       Date:  2019-10-07       Impact factor: 13.007

Review 6.  Melatonin for pre- and postoperative anxiety in adults.

Authors:  Melissa V Hansen; Natalie L Halladin; Jacob Rosenberg; Ismail Gögenur; Ann Merete Møller
Journal:  Cochrane Database Syst Rev       Date:  2015-04-09

Review 7.  Melatonin in Edible and Non-Edible Plants.

Authors:  Ufuk Koca Çalişkan; Ceylan Aka; Emrah Bor
Journal:  Turk J Pharm Sci       Date:  2017-04-15

Review 8.  The Safety of Melatonin in Humans.

Authors:  Lars Peter Holst Andersen; Ismail Gögenur; Jacob Rosenberg; Russel J Reiter
Journal:  Clin Drug Investig       Date:  2016-03       Impact factor: 2.859

Review 9.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

10.  Effects of melatonin on the nitric oxide treated retina.

Authors:  A W Siu; G G Ortiz; G Benitez-King; C H To; R J Reiter
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.